An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Public ClinicalTrials.gov record NCT01582061. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease (Seascape).
Study identification
- NCT ID
- NCT01582061
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 104 participants
Conditions and interventions
Conditions
Interventions
- Pasireotide sub-cutaneous Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2011
- Primary completion
- Jan 25, 2017
- Completion
- Jan 25, 2017
- Last update posted
- Jun 18, 2018
2011 – 2017
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Research, LLC | Peoria | Arizona | 85381 | — |
| St Josephs Hospital & Medical Center St Joes | Phoenix | Arizona | 85013 | — |
| University of California at Los Angeles UCLA Tiverton | Los Angeles | California | 90095 | — |
| LA Biomedical Research at Harbor UCLA Medical Center | Torrance | California | 90502 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| John H Stroger Jr Hospital of Cook County | Chicago | Illinois | 60644 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Diabetes and Endocrinology Associates, PC | Omaha | Nebraska | 68131 | — |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| University of New Mexico Hospital UNM | Albuquerque | New Mexico | 87106 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Oregon Health and Science University OHSU 5 | Portland | Oregon | 97239 | — |
| University of Pennsylvania Medical Center Univ Penn | Philadelphia | Pennsylvania | 19104 | — |
| Allegheny Endocrinology Associates | Pittsburgh | Pennsylvania | 15212 | — |
| Mid South Endocrine Associates | Nashville | Tennessee | 37203 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
| Swedish Cancer Institute Swedish Cancer Institute (SC) | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01582061, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01582061 live on ClinicalTrials.gov.